Department of Chest Diseases, Ankara Atatürk Sanatorium Training and Research Hospital, Health Sciences University, Turkey.
Turk J Med Sci. 2022 Dec;52(6):1785-1792. doi: 10.55730/1300-0144.5524. Epub 2022 Dec 21.
Chronic Obstructive Pulmonary Disease (COPD) is one of the most common causes of death worldwide. Therefore, optimizing medical therapy in the comprehensive management of the disease, as well as including pulmonary rehabilitation (PR) in the treatment, is essential. The goal of our study was to determine the impact of PR on the survival of COPD patients.
Between 2007-2015, 509 COPD patients who completed the PR constituted the PR group, while 167 patients who applied but could not complete it after the initial evaluations formed the control group. In the PR group, dyspnea perception, exercise capacity, muscle strength, body composition, quality of life, psychosocial status, and i-BODE scores were assessed at the beginning and end of the program, whereas in the control group, these assessments could only be conducted at the beginning. Also, after PR, our PR participants have prescribed a home exercise program, and they were recalled to the hospital at the 3rd, 6th, 12th, 18th, and 24th months for follow-up visits.
A statistically significant improvement was found in almost all the data (except FEV1/FVC, BORG after exercise, and FFMI) after PR. There was a statistically significant difference in 5-year survival in favor of the PR group (p = 0.006), and in PR patients who accompanied the home exercise program vs. those who did not (p = 0.000). Also the gains in MRC (p = 0.003; OR: 2.20; CI: 1.319- 3.682), MEP (p = 0.041; OR: 1.02; CI: 1.001-1.035), and i-BODE (p = 0.006; OR: 0.914; CI: 0.857-0.974) increased the survival.
Apart from incorporating PR into treatment in the comprehensive management of COPD, we demonstrated that maintaining a home exercise program for at least two years following PR increased 5-year survival significantly.
慢性阻塞性肺疾病(COPD)是全球最常见的死亡原因之一。因此,在疾病的综合管理中优化医学治疗,以及将肺康复(PR)纳入治疗,是至关重要的。我们的研究目的是确定 PR 对 COPD 患者生存的影响。
在 2007 年至 2015 年期间,完成 PR 的 509 例 COPD 患者组成 PR 组,而在初始评估后无法完成 PR 的 167 例患者组成对照组。在 PR 组中,在计划开始和结束时评估呼吸困难感知、运动能力、肌肉力量、身体成分、生活质量、社会心理状态和 i-BODE 评分,而在对照组中,只能在开始时进行这些评估。此外,在 PR 之后,我们的 PR 参与者被规定了一个家庭运动计划,并在第 3、6、12、18 和 24 个月被召回医院进行随访。
PR 后几乎所有数据(除了 FEV1/FVC、运动后 BORG 和 FFMI)都有显著改善。PR 组的 5 年生存率有统计学显著差异(p=0.006),并且在伴有家庭运动计划的 PR 患者与不伴有家庭运动计划的患者之间存在统计学显著差异(p=0.000)。此外,MRC(p=0.003;OR:2.20;CI:1.319-3.682)、MEP(p=0.041;OR:1.02;CI:1.001-1.035)和 i-BODE(p=0.006;OR:0.914;CI:0.857-0.974)的改善增加了生存率。
除了将 PR 纳入 COPD 的综合管理治疗外,我们还证明,在 PR 后至少两年内维持家庭运动计划可显著提高 5 年生存率。